Share on StockTwits

Ovascience (NASDAQ:OVAS) Director Harald F. Stock bought 1,063 shares of the stock in a transaction that occurred on Tuesday, June 3rd. The shares were purchased at an average cost of $7.01 per share, for a total transaction of $7,451.63. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Ovascience (NASDAQ:OVAS) opened at 7.47 on Friday. Ovascience has a 52 week low of $5.509 and a 52 week high of $16.00. The stock’s 50-day moving average is $7.47 and its 200-day moving average is $8.92. The company’s market cap is $174.4 million.

Ovascience (NASDAQ:OVAS) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.41) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.46) by $0.05. Analysts expect that Ovascience will post $-1.92 EPS for the current fiscal year.

OVAS has been the subject of a number of recent research reports. Analysts at HC Wainwright reiterated a “buy” rating on shares of Ovascience in a research note on Monday, May 12th. Separately, analysts at Oppenheimer initiated coverage on shares of Ovascience in a research note on Tuesday, April 29th. They set an “outperform” rating and a $11.00 price target on the stock. Finally, analysts at Leerink Swann raised their price target on shares of Ovascience to $16.00 in a research note on Thursday, April 3rd.

OvaScience, Inc, is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.